Found: 15
Select item for more details and to access through your institution.
Comments on "Statistical methodology for highly variable compounds: A novel design approach for the ofatumumab phase 2 bioequivalence study".
- Published in:
- Pharmaceutical Statistics, 2022, v. 21, n. 6, p. 1366, doi. 10.1002/pst.2255
- By:
- Publication type:
- Article
On Bayesian Analysis and Hypothesis Testing in the Determination of Bioequivalence.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 304, doi. 10.1002/cpt.1291
- By:
- Publication type:
- Article
Optimal adaptive sequential designs for crossover bioequivalence studies.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 1, p. 15, doi. 10.1002/pst.1721
- By:
- Publication type:
- Article
Erratum to: A Bioequivalence Approach for Generic Narrow Therapeutic Index Drugs: Evaluation of the Reference-Scaled Approach and Variability Comparison Criterion.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
A Bioequivalence Approach for Generic Narrow Therapeutic Index Drugs: Evaluation of the Reference-Scaled Approach and Variability Comparison Criterion.
- Published in:
- AAPS Journal, 2015, v. 17, n. 4, p. 891, doi. 10.1208/s12248-015-9753-5
- By:
- Publication type:
- Article
Use of Partial AUC (PAUC) to Evaluate Bioequivalence-A Case Study with Complex Absorption: Methylphenidate.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 1, p. 191, doi. 10.1007/s11095-012-0862-x
- By:
- Publication type:
- Article
Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Generic Drug Products by the US Food and Drug Administration.
- Published in:
- AAPS Journal, 2012, v. 14, n. 4, p. 915, doi. 10.1208/s12248-012-9406-x
- By:
- Publication type:
- Article
Additional results for 'Sequential design approaches for bioequivalence studies with crossover designs'.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 1, p. 8, doi. 10.1002/pst.483
- By:
- Publication type:
- Article
Sequential design approaches for bioequivalence studies with crossover designs.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 4, p. 245, doi. 10.1002/pst.294
- By:
- Publication type:
- Article
Evaluation of a Scaling Approach for the Bioequivalence of Highly Variable Drugs.
- Published in:
- AAPS Journal, 2008, v. 10, n. 3, p. 450, doi. 10.1208/s12248-008-9053-4
- By:
- Publication type:
- Article
Evaluation of a Scaling Approach for the Bioequivalence of Highly Variable Drugs.
- Published in:
- 2008
- By:
- Publication type:
- Correction notice
Bioequivalence Approaches for Highly Variable Drugs and Drug Products.
- Published in:
- Pharmaceutical Research, 2008, v. 25, n. 1, p. 237, doi. 10.1007/s11095-007-9434-x
- By:
- Publication type:
- Article
Pharmacokinetic analysis of bioequivalence trials: Implications for sex-related issues in clinical pharmacology and biopharmaceutics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 5, p. 510, doi. 10.1067/mcp.2000.111184
- By:
- Publication type:
- Article
An individual bioequivalence criterion: regulatory considerations.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Thiazides XI: Partitioning of chlorothiazide in red blood cells after oral administration.
- Published in:
- Biopharmaceutics & Drug Disposition, 1984, v. 5, n. 1, p. 55, doi. 10.1002/bdd.2510050108
- By:
- Publication type:
- Article